EARNEST Partners’s Molina Healthcare MOH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-33
| Closed | -$10.8K | – | 785 |
|
|
2023
Q3 | $10.8K | Hold |
33
| – | – | ﹤0.01% | 617 |
|
|
2023
Q2 | $9.94K | Sell |
33
-12
| -27% | -$3.45K | ﹤0.01% | 640 |
|
|
2023
Q1 | $12K | Sell |
45
-383,902
| -100% | -$110M | ﹤0.01% | 587 |
|
|
2022
Q4 | $127M | Sell |
383,947
-103,439
| -21% | -$35.1M | 0.78% | 39 |
|
|
2022
Q3 | $161M | Sell |
487,386
-4,178
| -0.8% | -$1.35M | 1.08% | 21 |
|
|
2022
Q2 | $137M | Sell |
491,564
-108,984
| -18% | -$32.9M | 0.92% | 31 |
|
|
2022
Q1 | $200M | Sell |
600,548
-16,730
| -3% | -$5.15M | 1.19% | 17 |
|
|
2021
Q4 | $196M | Sell |
617,278
-97,159
| -14% | -$28.9M | 1.13% | 20 |
|
|
2021
Q3 | $194M | Sell |
714,437
-13,257
| -2% | -$3.5M | 1.18% | 22 |
|
|
2021
Q2 | $184M | Sell |
727,694
-3,072
| -0.4% | -$772K | 1.08% | 26 |
|
|
2021
Q1 | $171M | Buy |
730,766
+61,739
| +9% | +$13.8M | 1.02% | 29 |
|
|
2020
Q4 | $142M | Buy |
669,027
+8,533
| +1% | +$1.76M | 0.98% | 29 |
|
|
2020
Q3 | $121M | Sell |
660,494
-2,248
| -0.3% | -$409K | 1.04% | 20 |
|
|
2020
Q2 | $118M | Buy |
662,742
+6,469
| +1% | +$1.1M | 1.11% | 17 |
|
|
2020
Q1 | $91.7M | Buy |
656,273
+17,458
| +3% | +$2.34M | 1.03% | 26 |
|
|
2019
Q4 | $86.7M | Buy |
638,815
+41,298
| +7% | +$5.2M | 0.68% | 62 |
|
|
2019
Q3 | $65.6M | Buy |
597,517
+2,923
| +0.5% | +$379K | 0.59% | 71 |
|
|
2019
Q2 | $85.1M | Sell |
594,594
-4,647
| -0.8% | -$637K | 0.77% | 48 |
|
|
2019
Q1 | $85.1M | Buy |
599,241
+9,833
| +2% | +$1.33M | 0.81% | 41 |
|
|
2018
Q4 | $68.5M | Sell |
589,408
-9,348
| -2% | -$1.23M | 0.75% | 50 |
|
|
2018
Q3 | $89M | Sell |
598,756
-1,645
| -0.3% | -$210K | 0.8% | 46 |
|
|
2018
Q2 | $58.8M | Buy |
600,401
+1,202
| +0.2% | +$105K | 0.55% | 76 |
|
|
2018
Q1 | $48.6M | Buy |
599,199
+10,058
| +2% | +$809K | 0.46% | 88 |
|
|
2017
Q4 | $45.2M | Sell |
589,141
-31,137
| -5% | -$2.25M | 0.43% | 90 |
|
|
2017
Q3 | $42.6M | Sell |
620,278
-5,617
| -0.9% | -$366K | 0.42% | 88 |
|
|
2017
Q2 | $43.3M | Sell |
625,895
-565,758
| -47% | -$34.7M | 0.45% | 87 |
|
|
2017
Q1 | $54.3M | Sell |
1,191,653
-14,782
| -1% | -$774K | 0.58% | 70 |
|
|
2016
Q4 | $65.5M | Sell |
1,206,435
-104,992
| -8% | -$5.74M | 0.71% | 48 |
|
|
2016
Q3 | $76.5M | Sell |
1,311,427
-55,618
| -4% | -$3.07M | 0.8% | 40 |
|
|
2016
Q2 | $68.2M | Sell |
1,367,045
-12,513
| -0.9% | -$669K | 0.74% | 45 |
|
|
2016
Q1 | $89M | Sell |
1,379,558
-25,142
| -2% | -$1.49M | 0.93% | 26 |
|
|
2015
Q4 | $84.5M | Sell |
1,404,700
-50,558
| -3% | -$3.19M | 0.86% | 31 |
|
|
2015
Q3 | $100M | Sell |
1,455,258
-43,425
| -3% | -$3.22M | 0.98% | 25 |
|
|
2015
Q2 | $105M | Buy |
1,498,683
+5,055
| +0.3% | +$338K | 0.92% | 30 |
|
|
2015
Q1 | $101M | Sell |
1,493,628
-160,659
| -10% | -$9.28M | 0.87% | 37 |
|
|
2014
Q4 | $88.6M | Sell |
1,654,287
-6,183
| -0.4% | -$299K | 0.73% | 51 |
|
|
2014
Q3 | $70.2M | Buy |
1,660,470
+1,347,637
| +431% | +$59.6M | 0.59% | 60 |
|
|
2014
Q2 | $14M | Buy |
+312,833
| New | +$12.7M | 0.11% | 160 |
|
Other funds holding MOH
EARNEST Partners's MOH Position: Q4 2023 in Review
EARNEST Partners sold out of Molina Healthcare (MOH) in Q4 2023, closing a stake of 33 shares — an estimated $10.8K sold.
EARNEST Partners first reported a position in MOH in Q2 2014 and held it in 38 quarters. The position peaked at $200M in Q1 2022. 609 funds tracked by Wall St. Rank hold MOH as of Q4 2023.
- EARNEST Partners reported no remaining Molina Healthcare position as of Q4 2023 after selling out during the quarter.
- EARNEST Partners sold 33 Molina Healthcare shares in Q4 2023, an estimated $10.8K.
- EARNEST Partners first reported a position in Molina Healthcare in Q2 2014 and held it in 38 quarters.
- EARNEST Partners's Molina Healthcare position peaked at $200M in Q1 2022.
- 609 funds tracked by Wall St. Rank held Molina Healthcare as of Q4 2023.
Based on EARNEST Partners's 13F filing for Q4 2023, filed 14 Feb 2024.